Trevi Therapeutics, Inc. — Form D/A
Trevi Therapeutics, Inc. of NEW HAVEN, CT, a company, filed a Form D amendment with the SEC on 2018-09-05. The offering totals $61.9M, of which $51.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-09-05
- Form: D/A
- Accession: 0001563880-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $61.9M
- Amount sold: $51.9M
- Remaining: $10.0M
- Investors: 18
- Date of first sale: 2017-07-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-291383
Issuer
- Name: Trevi Therapeutics, Inc.
- CIK: 0001563880
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 195 CHURCH STREET, NEW HAVEN, CT, 06510
- Phone: 203-304-2499
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Mette Kirstine Agger | Director | CAMBRIDGE, MA |
| Ed L Mathers | Director | New Haven, CT |
| David R Meeker | Director | New Haven, CT |
| Annie L Mitsak | Director | New Haven, CT |
| Eran L Nadav | Director | New Haven, CT |
| Thomas R Sciascia | Executive Officer | New Haven, CT |
| Chris Kirstine Seiter | Executive Officer | New Haven, CT |
| Michael L Heffernan | Director | New Haven, CT |
| Thomas L Sciascia | Executive Officer | New Haven, CT |
| David L Meeker | Director | New Haven, CT |
| James L Cassella | Director | New Haven, CT |
| Dominick L Colangelo | Director | New Haven, CT |
| Jennifer L Good | Director | New Haven, CT |
| Jennifer L Good | Executive Officer | New Haven, CT |
| William L Forbes | Executive Officer | New Haven, CT |
| Edward L Mathers | Director | New Haven, CT |
| Anne L VanLent | Director | New Haven, CT |
| Lisa L Delfini | Executive Officer | New Haven, CT |
| Joseph R Sorrentino | Executive Officer | Hammondsport, NY |
| Cayce L Denton | Director | New Haven, CT |
| Otello Kirstine Stampacchia | Director | New Haven, CT |
Other filings by this issuer (5)
More